Oral immunotherapy (OIT) is a promising therapeutic approach for treating food allergy.
Introduction

21
Food allergies are recognized as a global medical problem that affects more than 25% of it has been reported that estimates are about 5% in children and 3% to 4% among adults (4). 26 Egg allergy is the second most common cause of food allergies in children (5) and four 
32
At present, the main treatment for egg allergic patients is based on food avoidance; 33 however, this poses a challenge due to the omnipresence of eggs in a wide range of food 34 (11). Furthermore, it has been shown that avoidance could lead to a lower reactivity 35 threshold in human subjects (12). For these reasons, a therapeutic approach seems more 
51
With regards to EW OIT, the use of heated EW formulas has always been a common HOM'EW were subjected to in vitro gastric digestion at 5.7 mg/mL final concentration. In 102 brief, the digestions were performed in simulated gastric fluid (SGF, 35 mM NaCl) at pH Biologicals, Denver, CO, USA) by oral gavage twice a week for a duration of 4 weeks.
126
After the sensitization phase, EW-specific IgE activity was determined by ELISA to ensure 
162
Specific IgE and IgG levels were measured by coating the plates with 50 µg/ml of the intact 163 EW, OM or OVA and a similar procedure to that described above was followed. Murine 164 serum samples were diluted 1:5 for specific IgE and 1:1000 for specific IgG. at 450 nm using a microplate reader (iMark Microplate reader, Bio-Rad).
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Measurement of EW-specific IgA in fecal samples
180
In an effort to further elucidate the underlying mechanism occurring locally at the intestinal 181 level, mouse fecal pellets were freshly collected on a weekly basis from each mouse group 182 cage, and were submitted to the following extraction procedure. In brief, fecal pellets were 183 freeze-dried, diluted 1:7 (w/w) in PBS and homogenized by using a vortex. Samples were 
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Supernatants were carefully collected and centrifuged again at 9500 g for 10 min at 4ºC.
186
Concentrations of EW-specific IgA were determined using a sandwich ELISA procedure.
187
In brief, flat-bottom 96-well ELISA plates (Corning) were incubated with 100 µl/well of 188 EW (50µg/well) in 100 mM NaHCO 3 (pH 9.6) and stored overnight at 4°C. Plates were 
Results and discussion
246
High in vitro digestibility of HOM'EW
247
Digestibility of EW and HOM'EW were performed to assess digestibility by using an in 248 vitro system in two steps, which mimicked digestion in the stomach (gastric) and 249 duodenum (24). The HOM'EW was more susceptible to digestion than intact EW as shown to their resistance to denaturation and digestive enzymes (25). These data put together 293 strongly supports and augments our study in which the HOM'EW was able to induce 294 successful tolerance to EW sensitized mice, which may due to tolerogenic peptides present 295 in HOM'EW.
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Low histamine and EW-specific IgE activity post oral challenge.
297
Histamine concentration was checked in mice sera after oral challenge with EW ( Figure   298 5A). Both treated mouse groups had significantly less histamine than the positive group and 299 were similar to that of the negative group, which confirmed the success of OIT. Also EW-300 specific IgE antibody activity post oral challenge was less in both the treatment groups than 301 the positive group but significantly higher than negative group. Interestingly, the high dose 302 group showed higher EW-specific IgE activity than the low dose group (Fig 5B) . 
